Deutsche Bank Ag\ Eliem Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.77 - $8.4 $10,639 - $32,264	-3,841 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$8.01 - $13.15 $3,620 - $5,943	-452 Reduced 10.53%	3,841 $32,000
Q4 2021 Feb 11, 2022	BUY	$8.61 - $20.47 $1,980 - $4,708	230 Added 5.66%	4,293 $45,000
Q3 2021 Nov 04, 2021	BUY	$14.45 - $28.61 $58,710 - $116,242	4,063 New	4,063 $73,000

53.1M

Ticker ELYM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,567,700
Market Cap $109M
Description
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.